Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Completed

Conditions studied: HIV/AIDS

In brief

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.

Key facts

Study ID

NCT03279185

Run by

Harvard School of Public Health (HSPH)

People needed

334

Starts

2017-11-01

Expected to finish

2025-05-31

Last updated by the study team

2025-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Perinatal HIV infection as documented in the medical record;
• At or beyond their 18th birthday at the time of informed consent with no upper age limit;
• Willingness to provide access to existing medical records; and
• Willingness to participate and provide legal consent

You may not qualify if…

• Prisoner status

Where it is running

• University of Southern California — Los Angeles, California, United States
• David Geffen School of Medicine at UCLA — Los Angeles, California, United States
• Emory University School of Medicine — Atlanta, Georgia, United States
• Rush University Cook County Hospital Chicago — Chicago, Illinois, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• Boston Medical Center — Boston, Massachusetts, United States
• New York University School of Medicine — New York, New York, United States
• SUNY Stony Brook — Stony Brook, New York, United States
• Seattle Children's Hospital — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.